Abiopharma

🔍 MARROTT KARL TODD (Executive)

Company: TSS, Inc. (TSSI)

Report Date: 2026-03-23-05:00

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Common Stock (Direct)
  Date: 2026-03-23-05:00 | Code: A | equity_swap_involved: false | shares_owned_after: 291,545.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 609 shares of Common Stock at $12.4 per share (Direct)
  Date: 2026-03-23-05:00 | Code: F | equity_swap_involved: false | shares_owned_after: 290,936.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These shares of common stock represent restricted stock granted to Mr. Marrott that are subject to financial performance vesting criteria that has been achieved. The restricted stock vests in installments as follows assuming Mr. Marrott remains employed through the applicable vesting dates: (1) 2,500 shares vested on March 23, 2026, and (2) 2,500 shares will vest on January 1, 2027, and are subject to forfeiture.
• F2: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock awards.